Pharmacotherapy of Prograf (Tacrolimus) in Liver Transplant Recipients; Consideration of It's Levels with Efficacy and Toxicity
Author(s):
Abstract:
Context: Cytochrome P450 (CYP3A) enzymes are basic for the metabolism of several medications such as tacrolimus, as immunosuppression with tacrolimus in men prevents allograft rejection and reverses steroid-resistant rejection in transplanted recipients.
Evidence Acquisition: The aim of this study was to determine a proper guideline for tacrolimus (prograf) prescription after organ transplantation.
Evidence Acquisition: The aim of this study was to determine a proper guideline for tacrolimus (prograf) prescription after organ transplantation.
Methods
The key words relevant to topics of tarcolimus pharmacotherapy were searched. Consequently, articles related to efficacy and toxicity of tacrolimus in organ transplant recipients were selected and studied entirely.Results
The results showed that tacrolimus dosage might vary with the indication for transplantation, time after grafting, and the genotype of CYP3A. Hepatic dysfunction may impair drug disposition as a result of decreased metabolic activity through parenchymal damage and compromised biliary excretion of parent drug and metabolites during cholestasis.Conclusions
To avoid side effects, in prescribing tacrolimus such as acute rejection and toxicity, further investigation for more direct markers related to the differentiation between immunosuppressive activity due to parent drug and side effects due to metabolites within Iranian population of organ transplantation seems to be advantageous. Keywords:
Language:
English
Published:
Jentashapir Journal of Cellular and Molecular Biology, Volume:8 Issue: 1, Feb 2017
Page:
1
magiran.com/p1705152
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!